Brief: Qlife Signs LOI With South Korean Company Precision Biosensor
March 25 (Reuters) - Qlife Holding AB QLIFE.ST :
* QLIFE SIGNS LETTER OF INTENT WITH SOUTH KOREAN COMPANY
PRECISION
BIOSENSOR AS PART OF B2B STRATEGY TO ENTER MAJOR MARKETS WITH
EGOO HEALTH, THROUGH HOSPITAL@HOME PARTNERSHIPS
* ANTICIPATES FINALIZING A COMPREHENSIVE COLLABORATION
AGREEMENT
OVER NEXT MONTHS
Source text for Eikon: ID:nWkr1Wy0P0
Further company coverage: QLIFE.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Qlife Holding AB
See all newsAdvisory: Alerts on Qlife's agreement with global pharma company withdrawn
Brief: Qlife Holding Enters Feasibility Deal With Pharma Co For Egoo Health Biomarker
Brief: Qlife Holding Q1 EBITDA Loss SEK 5.5 Mln
Sweden's Qlife Q1 revenue drops, losses widen slightly
Brief: Qlife Holding Q4 EBITDA At SEK -1.6 Million